APO Research

APO RESEARCH · REPORT

Pharmaceutical Microbiology Testing

Selected research

Market Structure

Global Pharmaceutical Microbiology Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Pharmaceutical Microbiology Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmaceutical Microbiology Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Microbiology Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Microbiology Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical Microbiology Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Microbiology Testing include Eurofins Scientific, Charles River Laboratories, SGS, WuXi AppTec, Nelson Labs, Pace Analytical, Thermo Fisher Scientific, Merck KGaA / MilliporeSigma and bioMérieux, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmaceutical Microbiology Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Microbiology Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Microbiology Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical Microbiology Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Microbiology Testing Segment by Company

Eurofins Scientific

Charles River Laboratories

SGS

WuXi AppTec

Nelson Labs

Pace Analytical

Thermo Fisher Scientific

Merck KGaA / MilliporeSigma

bioMérieux

Sartorius

STERIS

Intertek

ALS Limited

Microbac Laboratories

Alcami

Almac Group

Labcorp Drug Development

Element Materials Technology

Toxikon

Aurigene Pharmaceutical Services

Toray Research Center

Centre Testing International Group

Pony Testing International Group

Sumika Chemical Analysis Service

CMIC Group

LSI Medience

Pharmaceutical Microbiology Testing Segment by Type

Culture-Based Testing

Rapid Microbial Testing

Molecular Testing

Automated Microbiology Testing

Others

Pharmaceutical Microbiology Testing Segment by Application

Pharmaceutical Industry

CRO/CDMO

Medical Device

Others

Pharmaceutical Microbiology Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Microbiology Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Microbiology Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Microbiology Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical Microbiology Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Microbiology Testing industry.

Chapter 3: Detailed analysis of Pharmaceutical Microbiology Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Microbiology Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Culture-Based Testing Table 3. Key Players of Rapid Microbial Testing Table 4. Key Players of Molecular Testing Table 3. Key Players of Automated Microbiology Testing Table 4. Key Players of Others Table 5. Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Pharmaceutical Industry Table 7. Key Players of CRO/CDMO Table 8. Key Players of Medical Device Table 9. Key Players of Others Table 10. Global Pharmaceutical Microbiology Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Pharmaceutical Microbiology Testing Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Pharmaceutical Microbiology Testing Market Share by Region (2021-2026) Table 13. Global Pharmaceutical Microbiology Testing Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Pharmaceutical Microbiology Testing Market Share by Region (2027-2032) Table 15. Pharmaceutical Microbiology Testing Industry Trends Table 16. Pharmaceutical Microbiology Testing Industry Drivers Table 17. Pharmaceutical Microbiology Testing Industry Opportunities and Challenges Table 18. Pharmaceutical Microbiology Testing Industry Restraints Table 19. Global Pharmaceutical Microbiology Testing Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Pharmaceutical Microbiology Testing Revenue Market Share by Company (2021-2026) Table 21. Global Pharmaceutical Microbiology Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Pharmaceutical Microbiology Testing Key Company Head Office and Area Served Table 23. Global Pharmaceutical Microbiology Testing Company, Product Type & Application Table 24. Global Pharmaceutical Microbiology Testing Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Pharmaceutical Microbiology Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Pharmaceutical Microbiology Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical Microbiology Testing Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical Microbiology Testing Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical Microbiology Testing Revenue Market Share by Type (2021-2026) Table 31. Global Pharmaceutical Microbiology Testing Revenue Market Share by Type (2027-2032) Table 32. Global Pharmaceutical Microbiology Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical Microbiology Testing Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical Microbiology Testing Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2021-2026) Table 36. Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2027-2032) Table 37. Eurofins Scientific Company Information Table 38. Eurofins Scientific Business Overview Table 39. Eurofins Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Eurofins Scientific Pharmaceutical Microbiology Testing Product Portfolio Table 41. Eurofins Scientific Recent Development Table 42. Charles River Laboratories Company Information Table 43. Charles River Laboratories Business Overview Table 44. Charles River Laboratories Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Charles River Laboratories Pharmaceutical Microbiology Testing Product Portfolio Table 46. Charles River Laboratories Recent Development Table 47. SGS Company Information Table 48. SGS Business Overview Table 49. SGS Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. SGS Pharmaceutical Microbiology Testing Product Portfolio Table 51. SGS Recent Development Table 52. WuXi AppTec Company Information Table 53. WuXi AppTec Business Overview Table 54. WuXi AppTec Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. WuXi AppTec Pharmaceutical Microbiology Testing Product Portfolio Table 56. WuXi AppTec Recent Development Table 57. Nelson Labs Company Information Table 58. Nelson Labs Business Overview Table 59. Nelson Labs Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Nelson Labs Pharmaceutical Microbiology Testing Product Portfolio Table 61. Nelson Labs Recent Development Table 62. Pace Analytical Company Information Table 63. Pace Analytical Business Overview Table 64. Pace Analytical Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Pace Analytical Pharmaceutical Microbiology Testing Product Portfolio Table 66. Pace Analytical Recent Development Table 67. Thermo Fisher Scientific Company Information Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Thermo Fisher Scientific Pharmaceutical Microbiology Testing Product Portfolio Table 71. Thermo Fisher Scientific Recent Development Table 72. Merck KGaA / MilliporeSigma Company Information Table 73. Merck KGaA / MilliporeSigma Business Overview Table 74. Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Product Portfolio Table 76. Merck KGaA / MilliporeSigma Recent Development Table 77. bioMérieux Company Information Table 78. bioMérieux Business Overview Table 79. bioMérieux Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. bioMérieux Pharmaceutical Microbiology Testing Product Portfolio Table 81. bioMérieux Recent Development Table 82. Sartorius Company Information Table 83. Sartorius Business Overview Table 84. Sartorius Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Sartorius Pharmaceutical Microbiology Testing Product Portfolio Table 86. Sartorius Recent Development Table 87. STERIS Company Information Table 88. STERIS Business Overview Table 89. STERIS Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. STERIS Pharmaceutical Microbiology Testing Product Portfolio Table 91. STERIS Recent Development Table 92. Intertek Company Information Table 93. Intertek Business Overview Table 94. Intertek Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Intertek Pharmaceutical Microbiology Testing Product Portfolio Table 96. Intertek Recent Development Table 97. ALS Limited Company Information Table 98. ALS Limited Business Overview Table 99. ALS Limited Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. ALS Limited Pharmaceutical Microbiology Testing Product Portfolio Table 101. ALS Limited Recent Development Table 102. Microbac Laboratories Company Information Table 103. Microbac Laboratories Business Overview Table 104. Microbac Laboratories Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Microbac Laboratories Pharmaceutical Microbiology Testing Product Portfolio Table 106. Microbac Laboratories Recent Development Table 107. Alcami Company Information Table 108. Alcami Business Overview Table 109. Alcami Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Alcami Pharmaceutical Microbiology Testing Product Portfolio Table 111. Alcami Recent Development Table 112. Almac Group Company Information Table 113. Almac Group Business Overview Table 114. Almac Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Almac Group Pharmaceutical Microbiology Testing Product Portfolio Table 116. Almac Group Recent Development Table 117. Labcorp Drug Development Company Information Table 118. Labcorp Drug Development Business Overview Table 119. Labcorp Drug Development Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Labcorp Drug Development Pharmaceutical Microbiology Testing Product Portfolio Table 121. Labcorp Drug Development Recent Development Table 122. Element Materials Technology Company Information Table 123. Element Materials Technology Business Overview Table 124. Element Materials Technology Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. Element Materials Technology Pharmaceutical Microbiology Testing Product Portfolio Table 126. Element Materials Technology Recent Development Table 127. Toxikon Company Information Table 128. Toxikon Business Overview Table 129. Toxikon Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. Toxikon Pharmaceutical Microbiology Testing Product Portfolio Table 131. Toxikon Recent Development Table 132. Aurigene Pharmaceutical Services Company Information Table 133. Aurigene Pharmaceutical Services Business Overview Table 134. Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 135. Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Product Portfolio Table 136. Aurigene Pharmaceutical Services Recent Development Table 137. Toray Research Center Company Information Table 138. Toray Research Center Business Overview Table 139. Toray Research Center Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 140. Toray Research Center Pharmaceutical Microbiology Testing Product Portfolio Table 141. Toray Research Center Recent Development Table 142. Centre Testing International Group Company Information Table 143. Centre Testing International Group Business Overview Table 144. Centre Testing International Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 145. Centre Testing International Group Pharmaceutical Microbiology Testing Product Portfolio Table 146. Centre Testing International Group Recent Development Table 147. Pony Testing International Group Company Information Table 148. Pony Testing International Group Business Overview Table 149. Pony Testing International Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 150. Pony Testing International Group Pharmaceutical Microbiology Testing Product Portfolio Table 151. Pony Testing International Group Recent Development Table 152. Sumika Chemical Analysis Service Company Information Table 153. Sumika Chemical Analysis Service Business Overview Table 154. Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 155. Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Product Portfolio Table 156. Sumika Chemical Analysis Service Recent Development Table 157. CMIC Group Company Information Table 158. CMIC Group Business Overview Table 159. CMIC Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 160. CMIC Group Pharmaceutical Microbiology Testing Product Portfolio Table 161. CMIC Group Recent Development Table 162. LSI Medience Company Information Table 163. LSI Medience Business Overview Table 164. LSI Medience Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 165. LSI Medience Pharmaceutical Microbiology Testing Product Portfolio Table 166. LSI Medience Recent Development Table 167. North America Pharmaceutical Microbiology Testing Market Size by Type (2021-2026) & (US$ Million) Table 168. North America Pharmaceutical Microbiology Testing Market Size by Type (2027-2032) & (US$ Million) Table 169. North America Pharmaceutical Microbiology Testing Market Size by Application (2021-2026) & (US$ Million) Table 170. North America Pharmaceutical Microbiology Testing Market Size by Application (2027-2032) & (US$ Million) Table 171. North America Pharmaceutical Microbiology Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. North America Pharmaceutical Microbiology Testing Market Size by Country (2021-2026) Table 173. North America Pharmaceutical Microbiology Testing Market Size by Country (2027-2032) Table 174. Europe Pharmaceutical Microbiology Testing Market Size by Type (2021-2026) & (US$ Million) Table 175. Europe Pharmaceutical Microbiology Testing Market Size by Type (2027-2032) & (US$ Million) Table 176. Europe Pharmaceutical Microbiology Testing Market Size by Application (2021-2026) & (US$ Million) Table 177. Europe Pharmaceutical Microbiology Testing Market Size by Application (2027-2032) & (US$ Million) Table 178. Europe Pharmaceutical Microbiology Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Pharmaceutical Microbiology Testing Market Size by Country (2021-2026) Table 180. Europe Pharmaceutical Microbiology Testing Market Size by Country (2027-2032) Table 181. China Pharmaceutical Microbiology Testing Market Size by Type (2021-2026) & (US$ Million) Table 182. China Pharmaceutical Microbiology Testing Market Size by Type (2027-2032) & (US$ Million) Table 183. China Pharmaceutical Microbiology Testing Market Size by Application (2021-2026) & (US$ Million) Table 184. China Pharmaceutical Microbiology Testing Market Size by Application (2027-2032) & (US$ Million) Table 185. Asia Pharmaceutical Microbiology Testing Market Size by Type (2021-2026) & (US$ Million) Table 186. Asia Pharmaceutical Microbiology Testing Market Size by Type (2027-2032) & (US$ Million) Table 187. Asia Pharmaceutical Microbiology Testing Market Size by Application (2021-2026) & (US$ Million) Table 188. Asia Pharmaceutical Microbiology Testing Market Size by Application (2027-2032) & (US$ Million) Table 189. Asia Pharmaceutical Microbiology Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Pharmaceutical Microbiology Testing Market Size by Country (2021-2026) Table 191. Asia Pharmaceutical Microbiology Testing Market Size by Country (2027-2032) Table 192. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Type (2021-2026) & (US$ Million) Table 193. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Type (2027-2032) & (US$ Million) Table 194. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Application (2021-2026) & (US$ Million) Table 195. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Application (2027-2032) & (US$ Million) Table 196. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2021-2026) Table 198. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2027-2032) Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Pharmaceutical Microbiology Testing Product Image Figure 2. Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmaceutical Microbiology Testing Market Share by Type: 2025 VS 2032 Figure 4. Culture-Based Testing Image Figure 5. Rapid Microbial Testing Image Figure 6. Molecular Testing Image Figure 7. Automated Microbiology Testing Image Figure 8. Others Image Figure 9. Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Pharmaceutical Microbiology Testing Market Share by Application: 2025 VS 2032 Figure 11. Pharmaceutical Industry Image Figure 12. CRO/CDMO Image Figure 13. Medical Device Image Figure 14. Others Image Figure 15. Global Pharmaceutical Microbiology Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 17. Global Pharmaceutical Microbiology Testing Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Pharmaceutical Microbiology Testing Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Pharmaceutical Microbiology Testing Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Pharmaceutical Microbiology Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharmaceutical Microbiology Testing Revenue Market Share by Type (2021-2032) Figure 24. Global Pharmaceutical Microbiology Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2021-2032) Figure 26. North America Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 27. North America Pharmaceutical Microbiology Testing Market Share by Type (2021-2032) Figure 28. North America Pharmaceutical Microbiology Testing Market Share by Application (2021-2032) Figure 29. North America Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 30. United States Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 31. Canada Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 33. Europe Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 34. Europe Pharmaceutical Microbiology Testing Market Share by Type (2021-2032) Figure 35. Europe Pharmaceutical Microbiology Testing Market Share by Application (2021-2032) Figure 36. Europe Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 37. Germany Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 38. France Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 40. Italy Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 41. Russia Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 43. China Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 44. China Pharmaceutical Microbiology Testing Market Share by Type (2021-2032) Figure 45. China Pharmaceutical Microbiology Testing Market Share by Application (2021-2032) Figure 46. Asia Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 47. Asia Pharmaceutical Microbiology Testing Market Share by Type (2021-2032) Figure 48. Asia Pharmaceutical Microbiology Testing Market Share by Application (2021-2032) Figure 49. Asia Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 50. Japan Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 54. India Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 55. Australia Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 60. Brazil Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 65. UAE Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 67. Chile Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Culture-Based Testing
  • Rapid Microbial Testing
  • Molecular Testing
  • Automated Microbiology Testing
  • Others
Applications
  • Pharmaceutical Industry
  • CRO/CDMO
  • Medical Device
  • Others
Companies covered
  • Eurofins Scientific
  • Charles River Laboratories
  • SGS
  • WuXi AppTec
  • Nelson Labs
  • Pace Analytical
  • Thermo Fisher Scientific
  • Merck KGaA / MilliporeSigma
  • bioMérieux
  • Sartorius
  • STERIS
  • Intertek
  • ALS Limited
  • Microbac Laboratories
  • Alcami
  • Almac Group
  • Labcorp Drug Development
  • Element Materials Technology
  • Toxikon
  • Aurigene Pharmaceutical Services
  • Toray Research Center
  • Centre Testing International Group
  • Pony Testing International Group
  • Sumika Chemical Analysis Service
  • CMIC Group
  • LSI Medience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Culture-Based Testing
  5. 1.2.3 Rapid Microbial Testing
  6. 1.2.4 Molecular Testing
  7. 1.2.5 Automated Microbiology Testing
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Pharmaceutical Microbiology Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Pharmaceutical Industry
  12. 1.3.3 CRO/CDMO
  13. 1.3.4 Medical Device
  14. 1.3.5 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Pharmaceutical Microbiology Testing Growth Trends by Region
  17. 1.5.1 Global Pharmaceutical Microbiology Testing Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Pharmaceutical Microbiology Testing Market Size by Region (2021-2026)
  19. 1.5.3 Pharmaceutical Microbiology Testing Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Pharmaceutical Microbiology Testing Market Dynamics
  1. 2.1 Pharmaceutical Microbiology Testing Industry Trends
  2. 2.2 Pharmaceutical Microbiology Testing Industry Drivers
  3. 2.3 Pharmaceutical Microbiology Testing Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Microbiology Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmaceutical Microbiology Testing Revenue by Company (2021-2026)
  2. 3.2 Global Pharmaceutical Microbiology Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmaceutical Microbiology Testing Key Company Head office and Area Served
  4. 3.4 Global Pharmaceutical Microbiology Testing Company, Product Type & Application
  5. 3.5 Global Pharmaceutical Microbiology Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmaceutical Microbiology Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmaceutical Microbiology Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmaceutical Microbiology Testing Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Microbiology Testing Market by Type
  1. 4.1 Global Pharmaceutical Microbiology Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmaceutical Microbiology Testing Market Size by Type (2021-2032)
  3. 4.3 Global Pharmaceutical Microbiology Testing Market Size Share by Type (2021-2032)
5 Pharmaceutical Microbiology Testing Market by Application
  1. 5.1 Global Pharmaceutical Microbiology Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Microbiology Testing Market Size by Application (2021-2032)
  3. 5.3 Global Pharmaceutical Microbiology Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eurofins Scientific
  2. 6.1.1 Eurofins Scientific Company Information
  3. 6.1.2 Eurofins Scientific Business Overview
  4. 6.1.3 Eurofins Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eurofins Scientific Pharmaceutical Microbiology Testing Product Portfolio
  6. 6.1.5 Eurofins Scientific Recent Developments
  7. 6.2 Charles River Laboratories
  8. 6.2.1 Charles River Laboratories Company Information
  9. 6.2.2 Charles River Laboratories Business Overview
  10. 6.2.3 Charles River Laboratories Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Charles River Laboratories Pharmaceutical Microbiology Testing Product Portfolio
  12. 6.2.5 Charles River Laboratories Recent Developments
  13. 6.3 SGS
  14. 6.3.1 SGS Company Information
  15. 6.3.2 SGS Business Overview
  16. 6.3.3 SGS Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 SGS Pharmaceutical Microbiology Testing Product Portfolio
  18. 6.3.5 SGS Recent Developments
  19. 6.4 WuXi AppTec
  20. 6.4.1 WuXi AppTec Company Information
  21. 6.4.2 WuXi AppTec Business Overview
  22. 6.4.3 WuXi AppTec Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 WuXi AppTec Pharmaceutical Microbiology Testing Product Portfolio
  24. 6.4.5 WuXi AppTec Recent Developments
  25. 6.5 Nelson Labs
  26. 6.5.1 Nelson Labs Company Information
  27. 6.5.2 Nelson Labs Business Overview
  28. 6.5.3 Nelson Labs Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Nelson Labs Pharmaceutical Microbiology Testing Product Portfolio
  30. 6.5.5 Nelson Labs Recent Developments
  31. 6.6 Pace Analytical
  32. 6.6.1 Pace Analytical Company Information
  33. 6.6.2 Pace Analytical Business Overview
  34. 6.6.3 Pace Analytical Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pace Analytical Pharmaceutical Microbiology Testing Product Portfolio
  36. 6.6.5 Pace Analytical Recent Developments
  37. 6.7 Thermo Fisher Scientific
  38. 6.7.1 Thermo Fisher Scientific Company Information
  39. 6.7.2 Thermo Fisher Scientific Business Overview
  40. 6.7.3 Thermo Fisher Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Thermo Fisher Scientific Pharmaceutical Microbiology Testing Product Portfolio
  42. 6.7.5 Thermo Fisher Scientific Recent Developments
  43. 6.8 Merck KGaA / MilliporeSigma
  44. 6.8.1 Merck KGaA / MilliporeSigma Company Information
  45. 6.8.2 Merck KGaA / MilliporeSigma Business Overview
  46. 6.8.3 Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Product Portfolio
  48. 6.8.5 Merck KGaA / MilliporeSigma Recent Developments
  49. 6.9 bioMérieux
  50. 6.9.1 bioMérieux Company Information
  51. 6.9.2 bioMérieux Business Overview
  52. 6.9.3 bioMérieux Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 bioMérieux Pharmaceutical Microbiology Testing Product Portfolio
  54. 6.9.5 bioMérieux Recent Developments
  55. 6.10 Sartorius
  56. 6.10.1 Sartorius Company Information
  57. 6.10.2 Sartorius Business Overview
  58. 6.10.3 Sartorius Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sartorius Pharmaceutical Microbiology Testing Product Portfolio
  60. 6.10.5 Sartorius Recent Developments
  61. 6.11 STERIS
  62. 6.11.1 STERIS Company Information
  63. 6.11.2 STERIS Business Overview
  64. 6.11.3 STERIS Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 STERIS Pharmaceutical Microbiology Testing Product Portfolio
  66. 6.11.5 STERIS Recent Developments
  67. 6.12 Intertek
  68. 6.12.1 Intertek Company Information
  69. 6.12.2 Intertek Business Overview
  70. 6.12.3 Intertek Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Intertek Pharmaceutical Microbiology Testing Product Portfolio
  72. 6.12.5 Intertek Recent Developments
  73. 6.13 ALS Limited
  74. 6.13.1 ALS Limited Company Information
  75. 6.13.2 ALS Limited Business Overview
  76. 6.13.3 ALS Limited Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 ALS Limited Pharmaceutical Microbiology Testing Product Portfolio
  78. 6.13.5 ALS Limited Recent Developments
  79. 6.14 Microbac Laboratories
  80. 6.14.1 Microbac Laboratories Company Information
  81. 6.14.2 Microbac Laboratories Business Overview
  82. 6.14.3 Microbac Laboratories Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Microbac Laboratories Pharmaceutical Microbiology Testing Product Portfolio
  84. 6.14.5 Microbac Laboratories Recent Developments
  85. 6.15 Alcami
  86. 6.15.1 Alcami Company Information
  87. 6.15.2 Alcami Business Overview
  88. 6.15.3 Alcami Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Alcami Pharmaceutical Microbiology Testing Product Portfolio
  90. 6.15.5 Alcami Recent Developments
  91. 6.16 Almac Group
  92. 6.16.1 Almac Group Company Information
  93. 6.16.2 Almac Group Business Overview
  94. 6.16.3 Almac Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Almac Group Pharmaceutical Microbiology Testing Product Portfolio
  96. 6.16.5 Almac Group Recent Developments
  97. 6.17 Labcorp Drug Development
  98. 6.17.1 Labcorp Drug Development Company Information
  99. 6.17.2 Labcorp Drug Development Business Overview
  100. 6.17.3 Labcorp Drug Development Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Labcorp Drug Development Pharmaceutical Microbiology Testing Product Portfolio
  102. 6.17.5 Labcorp Drug Development Recent Developments
  103. 6.18 Element Materials Technology
  104. 6.18.1 Element Materials Technology Company Information
  105. 6.18.2 Element Materials Technology Business Overview
  106. 6.18.3 Element Materials Technology Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Element Materials Technology Pharmaceutical Microbiology Testing Product Portfolio
  108. 6.18.5 Element Materials Technology Recent Developments
  109. 6.19 Toxikon
  110. 6.19.1 Toxikon Company Information
  111. 6.19.2 Toxikon Business Overview
  112. 6.19.3 Toxikon Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Toxikon Pharmaceutical Microbiology Testing Product Portfolio
  114. 6.19.5 Toxikon Recent Developments
  115. 6.20 Aurigene Pharmaceutical Services
  116. 6.20.1 Aurigene Pharmaceutical Services Company Information
  117. 6.20.2 Aurigene Pharmaceutical Services Business Overview
  118. 6.20.3 Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Product Portfolio
  120. 6.20.5 Aurigene Pharmaceutical Services Recent Developments
  121. 6.21 Toray Research Center
  122. 6.21.1 Toray Research Center Company Information
  123. 6.21.2 Toray Research Center Business Overview
  124. 6.21.3 Toray Research Center Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Toray Research Center Pharmaceutical Microbiology Testing Product Portfolio
  126. 6.21.5 Toray Research Center Recent Developments
  127. 6.22 Centre Testing International Group
  128. 6.22.1 Centre Testing International Group Company Information
  129. 6.22.2 Centre Testing International Group Business Overview
  130. 6.22.3 Centre Testing International Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Centre Testing International Group Pharmaceutical Microbiology Testing Product Portfolio
  132. 6.22.5 Centre Testing International Group Recent Developments
  133. 6.23 Pony Testing International Group
  134. 6.23.1 Pony Testing International Group Company Information
  135. 6.23.2 Pony Testing International Group Business Overview
  136. 6.23.3 Pony Testing International Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Pony Testing International Group Pharmaceutical Microbiology Testing Product Portfolio
  138. 6.23.5 Pony Testing International Group Recent Developments
  139. 6.24 Sumika Chemical Analysis Service
  140. 6.24.1 Sumika Chemical Analysis Service Company Information
  141. 6.24.2 Sumika Chemical Analysis Service Business Overview
  142. 6.24.3 Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Product Portfolio
  144. 6.24.5 Sumika Chemical Analysis Service Recent Developments
  145. 6.25 CMIC Group
  146. 6.25.1 CMIC Group Company Information
  147. 6.25.2 CMIC Group Business Overview
  148. 6.25.3 CMIC Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 CMIC Group Pharmaceutical Microbiology Testing Product Portfolio
  150. 6.25.5 CMIC Group Recent Developments
  151. 6.26 LSI Medience
  152. 6.26.1 LSI Medience Company Information
  153. 6.26.2 LSI Medience Business Overview
  154. 6.26.3 LSI Medience Pharmaceutical Microbiology Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 LSI Medience Pharmaceutical Microbiology Testing Product Portfolio
  156. 6.26.5 LSI Medience Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical Microbiology Testing Market Size by Type
  3. 7.2.1 North America Pharmaceutical Microbiology Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmaceutical Microbiology Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmaceutical Microbiology Testing Market Share by Type (2021-2032)
  6. 7.3 North America Pharmaceutical Microbiology Testing Market Size by Application
  7. 7.3.1 North America Pharmaceutical Microbiology Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmaceutical Microbiology Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmaceutical Microbiology Testing Market Share by Application (2021-2032)
  10. 7.4 North America Pharmaceutical Microbiology Testing Market Size by Country
  11. 7.4.1 North America Pharmaceutical Microbiology Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmaceutical Microbiology Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmaceutical Microbiology Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmaceutical Microbiology Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical Microbiology Testing Market Size by Type
  3. 8.2.1 Europe Pharmaceutical Microbiology Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmaceutical Microbiology Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmaceutical Microbiology Testing Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmaceutical Microbiology Testing Market Size by Application
  7. 8.3.1 Europe Pharmaceutical Microbiology Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmaceutical Microbiology Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmaceutical Microbiology Testing Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmaceutical Microbiology Testing Market Size by Country
  11. 8.4.1 Europe Pharmaceutical Microbiology Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmaceutical Microbiology Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmaceutical Microbiology Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmaceutical Microbiology Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 9.2 China Pharmaceutical Microbiology Testing Market Size by Type
  3. 9.2.1 China Pharmaceutical Microbiology Testing Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmaceutical Microbiology Testing Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmaceutical Microbiology Testing Market Share by Type (2021-2032)
  6. 9.3 China Pharmaceutical Microbiology Testing Market Size by Application
  7. 9.3.1 China Pharmaceutical Microbiology Testing Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmaceutical Microbiology Testing Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmaceutical Microbiology Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 10.2 Asia Pharmaceutical Microbiology Testing Market Size by Type
  3. 10.2.1 Asia Pharmaceutical Microbiology Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmaceutical Microbiology Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmaceutical Microbiology Testing Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmaceutical Microbiology Testing Market Size by Application
  7. 10.3.1 Asia Pharmaceutical Microbiology Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmaceutical Microbiology Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmaceutical Microbiology Testing Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmaceutical Microbiology Testing Market Size by Country
  11. 10.4.1 Asia Pharmaceutical Microbiology Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmaceutical Microbiology Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmaceutical Microbiology Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmaceutical Microbiology Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmaceutical Microbiology Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research